ETERNATEAR

eternatear-logo

EternaTear is developing a next-generation therapy for the over-the-counter dry eye market. Dry eye is the inability of the tear film and lids to protect the surface of the eye, resulting in itching, burning, and pain. With a dozen or more underlying causes, dry eye is notoriously difficult to diagnose and treat, and if left untreated, it can lead to permanent corneal damage. Patients with even moderate dry eye can suffer from debilitating symptoms that lead to a drastically reduced quality of ... life. Current treatment options are limited, and most patients rely on over-the-counter eye drops for temporary relief. But because they neither treat the root cause nor appropriately address the symptoms, current products on the market fail to provide adequate relief and must be reapplied as often as 6-12 times every day. By pairing proven technologies with pioneering research, EternaTearâ„¢ is developing a product that is closest to natural tears. Using a previously unrecognized mechanism, EternaTearâ„¢ can remain on the eye for an extended period of time, reducing the number of applications per day and giving Dry Eye patients lasting relief.

#SimilarOrganizations #People #Financial #Website #More

ETERNATEAR

Social Links:

Industry:
Health Care Medical Pharmaceutical Therapeutics

Founded:
2018-01-01

Address:
Raleigh, North Carolina, United States

Country:
United States

Website Url:
http://www.eternatear.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
4.9 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins


Similar Organizations

avivomed-logo

Avivomed

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

elicio-therapeutics-logo

Elicio Therapeutics

Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.

emmetrope-logo

Emmetrope

Emmetrope is developing next-generation accommodative lenses.

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

pacylex-logo

Pacylex

Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

upstream-bio-logo

Upstream Bio

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Current Employees Featured

tim-willis_image

Tim Willis
Tim Willis CEO @ EternaTear
CEO

Founder


tim-willis_image

Tim Willis

Investors List

tom-vorisek_image

Tom Vorisek

Tom Vorisek investment in Series A - EternaTear

the-fan-fund_image

DeepWork Capital

DeepWork Capital investment in Series A - EternaTear

carolina-angel-network_image

Carolina Angel Network

Carolina Angel Network investment in Series A - EternaTear

duke-angel-net_image

Duke Angel Network

Duke Angel Network investment in Series A - EternaTear

keiretsu-capital_image

Keiretsu Capital

Keiretsu Capital investment in Series A - EternaTear

keiretsu-forum_image

Keiretsu Forum

Keiretsu Forum investment in Series A - EternaTear

band-of-angels_image

Band of Angels

Band of Angels investment in Series A - EternaTear

Official Site Inspections

http://www.eternatear.com Semrush global rank: 5.22 M Semrush visits lastest month: 1.56 K

  • Host name: 172.67.150.140
  • IP address: 172.67.150.140
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "EternaTear"

EternaTear - Crunchbase Company Profile & Funding

By pairing proven technologies with pioneering research, EternaTearâ„¢ is developing a product …See details»

EternaTearâ„¢ | The Next Generation Artificial Tear

By pairing proven technologies with pioneering research, EternaTearâ„¢ is developing a product …See details»

Team | EternaTearâ„¢

He earned a reputation as a team builder who could turn around an organization or business and consistently meet or exceed expectations and performance plans. In 2002 he and his family moved to the Alcon Ft. Worth Texas …See details»

Eternatear Company Profile | Management and Employees List

Jun 30, 2024 Using a previously unrecognized mechanism, EternaTear can remain on the …See details»

EternaTear Company Profile 2024: Valuation, Funding & Investors

EternaTear General Information Description. Developer of over-the-counter artificial tears …See details»

EternaTear's Leadership Team - Team members and org chart

Other teams at EternaTear. View all +8. Board of Directors. 11 members. CEO and Executive …See details»

Eternatear, Inc. Company Profile | Raleigh, NC | Competitors ...

Find company research, competitor information, contact details & financial data for Eternatear, …See details»

EternaTear - Company Profile - Tracxn

Oct 31, 2024 EternaTear ranks 19th among 48 active competitors. 14 of its competitors are …See details»

EternaTearâ„¢ | Med1 Ventures LLC

EternaTearâ„¢ is a group of seasoned healthcare product developers and ophthalmic experts with a proven track record; our team is responsible for developing artificial tears that generate more than $350M in annual revenue. …See details»

EternaTear - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . …See details»

EternaTear's Board of Directors - Team members and org chart

Other teams at EternaTear. View all. CEO and Executive Team. 3 members. Leadership …See details»

Eternatear - Overview, News & Similar companies | ZoomInfo.com

Oct 6, 2020 Eternatear contact info: Phone number: (919) 241-3200 Website: …See details»

EternaTear - VentureRadar

EternaTear’s revolutionary technology works by naturally binding each of the 3 tear film layers …See details»

EternaTear - Contacts, Employees, Board Members, Advisors

EternaTear is developing a next-generation therapy for the over-the-counter dry eye market.See details»

EternaTearâ„¢ Raises $4.9 Million in Oversubscribed Series A Funding

EternaTear is developing a novel artificial tear formulation designed to supplement all layers of …See details»

Gould & Ratner Represents Client EternaTear in Completing ...

Oct 7, 2020 Gould & Ratner, with Fred Tannenbaum as lead partner, and with the help of …See details»

News - EternaTear

EternaTearâ„¢ Raises $4.9 Million in Oversubscribed Series A Funding. News. RALEIGH, N.C., …See details»

Technology - EternaTear

EternaTear’s revolutionary technology works by naturally binding each of the 3 tear film layers …See details»

News - EternaTear

Oct 12, 2020 EternaTearâ„¢ Raises $4.9 Million in Oversubscribed Series A Funding. by Chris …See details»

Dry Eye | EternaTearâ„¢

Dry Eye affects 320 million people globally, and nearly 15% of the US population; and these …See details»

linkstock.net © 2022. All rights reserved